KPX Lifescience.Co.Ltd (114450) — Cash Flow Quality Index
KPX Lifescience.Co.Ltd (114450) has a Cash Flow Quality Index of 6.79x as of September 2025. Operating cash flow of ₩3.33 Billion exceeds net income of ₩490.19 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of KPX Lifescience.Co.Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
KPX Lifescience.Co.Ltd Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for KPX Lifescience.Co.Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see KPX Lifescience.Co.Ltd cash conversion from operations.
Annual Cash Flow Quality Index for KPX Lifescience.Co.Ltd (2015–2024)
Year-by-year earnings quality comparison for KPX Lifescience.Co.Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.34x | ₩525.49 Million | ₩1.56 Billion | ▼ -90.5% |
| 2019 | 3.55x | ₩4.24 Billion | ₩1.20 Billion | ▲ +38.9% |
| 2017 | 2.55x | ₩5.68 Billion | ₩2.22 Billion | ▲ +62.8% |
| 2016 | 1.57x | ₩7.07 Billion | ₩4.50 Billion | ▲ +50.5% |
| 2015 | 1.04x | ₩5.62 Billion | ₩5.39 Billion | — |